I am pleased and very honoured to announce on behalf of the Scientific Committee of the World Mitochondria Society the 8th World Congress on Targeting Mitochondria which will be held in Berlin, Germany, on October 23-24, 2017.
The general and overarching topics our 8th World Congress on Targeting Mitochondria is going to cover will not significantly deviate from topics discussed at preceding editions of our conference series. We will again focus on three major areas, which are first the role of mitochondrial dysfunction in etiology and pathogenesis of chronic diseases including aging, second how to assess and above all quantify mitochondrial dysfunction in vitro and in vivo and finally, third, how to target and manipulate mitochondrial function in order to develop future mitochondria-based therapies.
The progress made in Mitochondrial Medicine over the last few years is breath-taking. Our detailed knowledge about how mitochondria impact human health and longevity has been rapidly growing, so has the number of mitochondria-based clinical trials.
For the 8th edition of “Targeting Mitochondria”, the scientific committee will invite again key players, i.e. investigators who have been pushing the progress in their particular field of mitochondrial research over the last few years. Basic researches working at the bench in the laboratory, physicians treating patients suffering from mitochondrial disorders as well as representatives of companies working on the commercialization of mitochondria-targeted therapies are all welcome to our conference. We are convinced that our 8th World Congress on Targeting Mitochondria will be at least as exciting and as successful as our previous meetings.
Hot topics which are going to be highlighted this year include among others:
Recent advances on mitochondrial dysfunction in etiology and pathogenesis of human diseases and aging
• Mitochondria and Aging
• Mitochondria & Microbiota: the intriguing relationship
• Mitochondria & Redox Regulation
• Mitochondria & Viral Infection
• Mitochondria & Metabolic Syndrome
• Mitochondria & Neurodegenerative Diseases
• Mitochondria & Cancer
The challenge of qualitative and quantitative assessment of mitochondrial function in vitro and in vivo
• Mitochondria Quality Control
• Mitochondria Devices: New methods to detect mitochondria dysfunction
• Mitochondria as Biomarkers
• Presentation of practical cases
Recent Advances on targeting mitochondria: Clinical trials and potential mitochondria-based therapies
• Strategies to target Stem Cells
• Strategies to target Microbiota
• Strategies to target miRNA
• Strategies to replace mitochondria
• Clinical & Therapeutic Directions
We very much look forward to seeing you in Berlin for this exciting event.
President of the World MItochondria Society
Chairman of the Targeting Mitochondria 2017